Note: Ingredients listed on restricted chemical lists
EC/CAS
872-50-4
Name of the chemical
N-Methyl-2-Pyrrolidone; 1-methyl-2-pyrrolidone (NMP)
Concentration
1-5
EC/CAS
112-34-5
Name of the chemical
2-(2-butoxyethoxy)ethanol
Concentration
1-5
General Information
Revision date
2026-03-19
Product name
TRANSPARENT WB MONOCOAT
1.2.1 Relevant identified uses
Industrial applications
Manufacturer Name
PPG Industries, Inc
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H360, H373
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
19.1% (oral), 25.3% (dermal), 28% (inhalation)
Signal word
Danger
Hazard statements
May damage fertility or the unborn child. May cause damage to organs through prolonged or repeated exposure.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection. Do not breathe vapor.
Response
IF exposed or concerned: Get medical advice or attention.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Contains isothiazolinones. May cause allergic reaction. This product either contains formaldehyde or is capable of releasing formaldehyde above 0.5 ppm under certain conditions. Formaldehyde is a known cancer hazard, a skin sensitizer and a respiratory sensitizer. Avoid contact with skin and clothing. Wash thoroughly after handling. Emits toxic fumes when heated.
2.3 Other hazards
Prolonged or repeated contact may dry skin and cause irritation.
2.1 Classification of the substance or mixture
SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 19.1% (oral), 25.3% (dermal), 28% (inhalation)